home All News open_in_new Full Article

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery announced the financial results for its fourth quarter and fiscal year ending December 31, 2024 and provided a corporate update. 2024 Highlights and Recent Developments On […]


today 10 h. ago attach_file Other

attach_file Other
attach_file Culture
attach_file Other
attach_file Other
attach_file Economics
attach_file Economics


ID: 1611809750
Add Watch Country

arrow_drop_down